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From the Head and Neck Cancer Program at the H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. Amdur RJ, Mendenhall WM, Stringer SP, et al. Organ preservation with radiotherapy for T1-T2 carcinoma of the pyriform sinus. Head Neck. 2001; 23:353-362 .
The authors reported on 101 patients with T1-T2 carcinoma of the pyriform sinus treated at the University of Florida with radiation therapy with or without a planned neck dissection for organ preservation. Radiation therapy alone or combined with a planned neck dissection resulted in local control with larynx preservation in a high proportion of patients. Regional recurrence was the most common cause of failure after surgical treatment of oral tongue carcinoma. Elective neck dissection significantly reduced mortality due to regional recurrence and also increased the overall survival. There was no significant difference between elective radical neck dissection and selective I, II, and III neck dissection in the improvement of treatment results.
Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999; 91: 2081 -2086 .
This randomized clinical trial tested whether the addition of three cycles of chemotherapy using carboplatin plus 5-fluorouracil during standard radiation therapy would improve diseasefree survival in patients with stages III and IV (ie, advanced) oropharynx carcinoma. Three-year overall actuarial and disease-free survival rates were 51% (95% CI, 39% to 68%) vs 31% (95% CI, 18% to 49%), respectively, and 42% (95% CI, 30% to 57%) vs 20% (95% CI, 10% to 33%), respectively, for patients treated with combined modality vs radiation therapy alone (P=.02 and .04, respectively). The locoregional control rate was improved in arm B (66%; 95% CI, 51% to 78%) vs arm A (42%; 95% CI, 31% to 56%). Improvement in overall survival supports the use of concomitant chemotherapy as an adjunct to radiotherapy in the management of carcinoma of the oropharynx.
Lazarus CL, Logemann JA, Pauloski BR, et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope. 1996; 106:1157 -1166 .
The nature of swallowing problems was examined in nine patients treated primarily with external-beam radiation and adjuvant chemotherapy for newly diagnosed head and neck tumors. All subjects underwent videofluorographic examination of their swallowing. Swallow motility disorders were observed in both the oral and pharyngeal stages, including reduced posterior tongue base movement toward the posterior pharyngeal wall and reduced laryngeal elevation during the swallow. Oropharyngeal swallow efficiency measures were significantly lower in the irradiated patients than in age-matched normal subjects. Although treatment of head and neck cancer with external-beam radiation is designed to provide cancer cure and preserve organ functioning, oral and pharyngeal motility for swallowing can become compromised if externalbeam radiation treatment is provided to either the larynx or tongue base region. This SWOG-led Intergroup phase III study shows a clear-cut advantage for chemoradiotherapy over radiation alone in patients with advanced nasopharyngeal cancer. The 3-year survival rate for chemoradiation was 76% in contrast to 46% for radiation alone.
Posner MR, Glisson B, Frenette G, et al. Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. J Clin Oncol. 2001; 19: 1096 -1104 This admittedly small study that added docetaxel to chemotherapy with cisplatin plus 5-fluorouracil demonstrated a high antitumor effect when used as induction therapy for advanced had and neck cancers, albeit at a cost of appreciable morbidity. It serves as an excellent base from which to identify equally effective but less toxic regimens.
